These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10323396

  • 1. Mediation of the hepatic effects of growth hormone by its lipolytic activity.
    Piatti PM, Monti LD, Caumo A, Conti M, Magni F, Galli-Kienle M, Fochesato E, Pizzini A, Baldi L, Valsecchi G, Pontiroli AE.
    J Clin Endocrinol Metab; 1999 May; 84(5):1658-63. PubMed ID: 10323396
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
    [Abstract] [Full Text] [Related]

  • 3. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE, Manzoni MF, Malighetti ME, Lanzi R.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5813-8. PubMed ID: 11739444
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P, Rossetti P, Porcellati F, Pampanelli S, Candeloro P, Andreoli AM, Perriello G, Bolli GB, Fanelli CG.
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [Abstract] [Full Text] [Related]

  • 6. Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans.
    Gormsen LC, Jessen N, Gjedsted J, Gjedde S, Nørrelund H, Lund S, Christiansen JS, Nielsen S, Schmitz O, Møller N.
    J Clin Endocrinol Metab; 2007 May; 92(5):1834-42. PubMed ID: 17341555
    [Abstract] [Full Text] [Related]

  • 7. The control on growth hormone release by free fatty acids is maintained in acromegaly.
    Lanzi R, Losa M, Mignogna G, Caumo A, Pontiroli AE.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1234-8. PubMed ID: 10199760
    [Abstract] [Full Text] [Related]

  • 8. Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects.
    Lanzi R, Manzoni MF, Andreotti AC, Malighetti ME, Bianchi E, Sereni LP, Caumo A, Luzi L, Pontiroli AE.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2239-43. PubMed ID: 9215300
    [Abstract] [Full Text] [Related]

  • 9. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
    Rebrin K, Steil GM, Mittelman SD, Bergman RN.
    J Clin Invest; 1996 Aug 01; 98(3):741-9. PubMed ID: 8698866
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
    Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB, Umpleby AM.
    J Clin Endocrinol Metab; 2004 Jan 01; 89(1):425-32. PubMed ID: 14715881
    [Abstract] [Full Text] [Related]

  • 11. Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
    Nørrelund H, Nielsen S, Christiansen JS, Jørgensen JO, Møller N.
    Eur J Endocrinol; 2004 Jun 01; 150(6):779-87. PubMed ID: 15191347
    [Abstract] [Full Text] [Related]

  • 12. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
    Fanelli C, Calderone S, Epifano L, De Vincenzo A, Modarelli F, Pampanelli S, Perriello G, De Feo P, Brunetti P, Gerich JE.
    J Clin Invest; 1993 Oct 01; 92(4):1617-22. PubMed ID: 8408616
    [Abstract] [Full Text] [Related]

  • 13. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
    Nielsen S, Møller N, Pedersen SB, Christiansen JS, Jørgensen JO.
    J Clin Endocrinol Metab; 2002 Jul 01; 87(7):3274-8. PubMed ID: 12107236
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of ghrelin administration on glucose and lipid metabolism.
    Vestergaard ET, Djurhuus CB, Gjedsted J, Nielsen S, Møller N, Holst JJ, Jørgensen JO, Schmitz O.
    J Clin Endocrinol Metab; 2008 Feb 01; 93(2):438-44. PubMed ID: 18042651
    [Abstract] [Full Text] [Related]

  • 15. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.
    Am J Physiol Endocrinol Metab; 2002 Jun 01; 282(6):E1360-8. PubMed ID: 12006367
    [Abstract] [Full Text] [Related]

  • 16. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
    Lanzi R, Luzi L, Caumo A, Andreotti AC, Manzoni MF, Malighetti ME, Sereni LP, Pontiroli AE.
    Metabolism; 1999 Sep 01; 48(9):1152-6. PubMed ID: 10484056
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.
    Nielsen S, Møller N, Christiansen JS, Jørgensen JO.
    Diabetes; 2001 Oct 01; 50(10):2301-8. PubMed ID: 11574412
    [Abstract] [Full Text] [Related]

  • 18. Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects.
    Pontiroli AE, Lanzi R, Monti LD, Pozza G.
    J Endocrinol Invest; 1990 Jun 01; 13(6):539-42. PubMed ID: 2258583
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.
    Krag MB, Gormsen LC, Guo Z, Christiansen JS, Jensen MD, Nielsen S, Jørgensen JO.
    Am J Physiol Endocrinol Metab; 2007 Mar 01; 292(3):E920-7. PubMed ID: 17132823
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone, glucagon, and insulin response to depression of plasma free fatty acids and the effect of glucose infusion.
    Quabbe HJ, Ramek W, Luyckx AS.
    J Clin Endocrinol Metab; 1977 Feb 01; 44(2):383-91. PubMed ID: 838844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.